Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal α2 adrenergic receptors in the rat

Anesthesiology

Volumn 85, Issue 4, 1996, Pages 846-852

  Guo, Tian Zhi ^b   Poree, Lawrence ^b   Golden, Wendy ^b   Stein, Joshua ^b   Fujinaga, Masahiko ^b   Maze, Mervyn ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Alpha 2; Analgesic; Nitrous oxide receptors; Opiate adrenergic receptors

Indexed keywords

2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; NITROUS OXIDE; OPIATE RECEPTOR; YOHIMBINE;

ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE RELEASE; DOSE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL ANESTHESIA;

ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANIMALS; IMIDAZOLES; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NITROUS OXIDE; NOCICEPTORS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID; SPINAL CORD; YOHIMBINE;

EID: 0029858303     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199610000-00020     Document Type: Article

References (29)

1. Berkowitz BA, Ngai SH, Finck DA: Nitrous oxide "analgesia": Resemblance to opiate analgesia. Science 1976; 194:967-8
2. Yang JC, Clark WC, Ngai SH: Antagonism of nitrous oxide analgesia by naloxone in man. ANESTHESIOLOGY 1980; 52:414-17
3. Quock RM, Kouchich FJ, Tseng L-F: Does nitrous oxide induce release of brain opioid peptides? Pharmacology 1985; 30:95
4. Morris B, Livingston A: Effects of nitrous oxide exposure on metenkephalin levels in discrete areas of rat brain. Neurosci Lett 1984; 45:11-14
5. Way WL, Hosobuchi Y, Johnson BH, Eger EI, Bloom FE: Anesthesia does not increase opioid peptides in cerebrospinal fluid of humans. ANESTHESIOLOGY 1984; 60:43-5
6. Evans SF, Stringer M, Bukht MDG, Thomas WA, Tomlin SJ: Nitrous oxide inhalation does not influence plasma concentrations of b endorphin or metenkephalin-like immunoreactivity. Br J Anaesth 1985; 57:624-8
7. Widgor S, Wilcox GL: Central and systemic morphine-induced antinociception in mice: Contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther 1987; 242:90-95
8. Suh HH, Fujimoto JM, Tseng LF: Differential mechanisms mediating endorphin- and morphine-induced analgesia in mice. Eur J Pharmacol 1989; 168:61-70
9. Larsen JJ, Arnt J: Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats. Acta Pharmacol Toxicol 1984; 54:72-5
10. Kuraichi Y, Fukui K, Shiomi H, Akaike A, Takagi H: Microinjection of opioids into the nucleus reticularis gigantocellularis: Analgesia and increase in normetanephrine level in the spinal cord. Biochem Pharmacol 1978; 27:2756-8
11. Pang IH, Vasko MR: Effect of depletion of spinal cord norepinephrine on morphine-induced antinociception. Brain Res 1986; 371:171-6
12. MacDonald E, Scheinin M: Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J Physiol Pharmacol 1995; 46:241-58
13. Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Lalies MD, Lewis J, Lione L: Functional studies of specific imidazoline-2 receptor ligands. Ann NY Acad Sci 1995; 763:125-39
14. Arthur JM, Casanas SJ, Raymond JR: Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A. Biochem Pharmacol 1993; 45:2337-41
15. Watts VJ, Lawler CP, Gonzales AJ, Zhou QY, Civelli O, Nichols DE, Mailman RB. Spare receptors and intrinsic activity: Studies with D1 dopamine receptor agonists. Synapse 1995; 21:177-87
16. Guo T-Z, Buttermann AE, Jiang J-Y, Maze M: Dexmedetomidine injection into the locus coeruleus produces analgesia. ANESTHESIOLOGY 1996; 84:873-81
17. Levine JD, Gordon NC, Fields HL: Naloxone dose-dependently produces analgesia and hyperalgesia in postoperative pain. Nature 1979; 278:740-1
18. Gillman MA, Kok L, Lichtigveld FJ: Paradoxical effect of naloxone on nitrous oxide analgesia in man. Eur J Pharmacol 1981; 61:175-7
19. Chapman CR, Benedetti C: Nitrous oxide effects on cerebral evoked potential to pain, partial reversal with a narcotic antagonist. ANESTHESIOLOGY 1979; 51:135-8
20. Levine JD, Gordon NC, Fields HL: Naloxone fails to antagonize nitrous oxide analgesia for clinical pain. Pain 1982; 13:165-70
21. Quock RM, Graczak LM: Influence of narcotic antagonistic drugs upon nitrous oxide analgesia in mice. Brain Res 1988; 440:35-41
22. Zuniga JR, Joseph SA, Knigge KM: The effects of nitrous oxide on the central endogenous pro-opiomelanocortin system in the rat. Brain Res 1987; 420:57-65
23. Zuniga JR, Joseph SA, Knigge KM: The effects of nitrous oxide on the secretory activity of pro-opiomelanocortin peptides from the basal hypothalamic cells attached to cytodex beads in a superfusion in vitro system. Brain Res 1987; 420:66-72
24. Zuniga J, Joseph S, Knigge K. Nitrous oxide analgesia: Partial antagonism by naloxone and total reversal after periaqueductal gray lesions in the rat. Eur J Pharmacol 1987; 142:51-60
25. 7 into canine third ventricular cerebrospinal fluid. Anesth Analg 1995; 80:664-70
26. Fang F, Marczynski TJ, Proudfit HK: Projections from neurons in the ventrolateral periaqueductal gray to the spinally-projecting noradrenergic neurons in the A7 catecholamine cell group. Soc Neuroscience Abstracts 1995; 21:386
27. Kendig JJ, Savola MKT, Woodley SJ, Maze M: Alpha-2 adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord. Eur J Pharmacol. 1991; 192:293-300
28. Berkowitz BA, Finck AD, Hynes MD, Ngai SH: Tolerance to nitrous oxide analgesia in rats and mice. ANESTHESIOLOGY 1979; 51:309-312
29. Ngai SH, Finck AD: Prolonged exposure to nitrous oxide decreased opiate receptor density in rat brainstem. ANESTHESIOLOGY 1982; 57:26-30